Idiopathic Pulmonary Fibrosis

Current Clinical Trial

Name:

ALOFT-IPF

Description:

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Stage:

Recruiting

Principal Investigator:

Professor Cormac McCarthy

Sponsor:

Bristol-Myers Squibb

Network Partners